Comparative Pharmacology
Head-to-head clinical analysis: DIURIL versus HYDRO RIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIURIL versus HYDRO RIDE.
DIURIL vs HYDRO-RIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits sodium reabsorption in the distal convoluted tubule by blocking the sodium-chloride symporter, leading to increased excretion of sodium, chloride, and water.
Thiazide diuretic that inhibits sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium and water.
Adults: 500 mg to 1000 mg orally once or twice daily; maximum 2000 mg per day.
Initiate at 12.5-25 mg orally once daily. Titrate to 50-100 mg once daily. Maximum 200 mg per day.
None Documented
None Documented
Terminal elimination half-life is 6-15 hours (mean 10 hours). In renal impairment, half-life can exceed 24 hours.
Terminal half-life 4-6 hours (prolonged in renal impairment).
Primarily renal (90-95% excreted unchanged via glomerular filtration and tubular secretion); minimal biliary/fecal (<5%).
Primarily renal (50% unchanged; remainder as glucuronide conjugate); biliary/fecal <10%.
Category C
Category C
Thiazide Diuretic
Thiazide Diuretic